Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib? Tarantino P, Burstein HJ, Lin NU, Krop IE, et al. Ann Oncol 2021 Dec 20. pii: S0923-7534(21)04877.

Read + Share

Amedeo Smart

Independent Medical Education

Tarantino P, Burstein HJ, Lin NU, Krop IE, et al. Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib? Ann Oncol 2021 Dec 20. pii: S0923-7534(21)04877.
PMID: 34942341